行业
显示 21-30 个结果(共 44 个结果)
-
Drugs for Helicobacter Pylori Infection Market in China
The drugs for helicobacter pylori infection market in China is set to increase by US$ 5,855 百万来自 2021 到 2027, 代表复合年增长率 (复合年增长率) 的 14.2% 在预测期内.
-
Inhalation Preparations Market in China
The inhalation preparations market in China is poised to grow by US$ 3,951 期间百万 2021-2027, 复合年增长率为 12.8% 在预测期内, 据数据和分析公司 StrategyHelix 称.
-
Drug for Gastrointestinal Diseases Market in China
根据StrategyHelix, the drug for gastrointestinal diseases market in China is expected to increase by US$ 4,900 期间百万 2021-2027, 复合年增长率为 6.7% 在预测期内.
-
Quadrivalent Influenza Vaccine Market in China
The quadrivalent influenza vaccine market in China is set to increase by US$ 2,512 百万来自 2021 到 2027, 代表复合年增长率 (复合年增长率) 的 20.9% 在预测期内.
-
Shingles Vaccine Market in China
The shingles vaccine market in China is poised to grow by US$ 5,886 百万来自 2021 到 2027, 复合年增长率为 49.2% 在预测期内, 根据StrategyHelix.
-
HPV Vaccine Market in China
The HPV vaccine market in China is poised to grow by US$ 5,054 百万来自 2021 到 2027, 复合年增长率为 18.7% 在预测期内, 根据StrategyHelix.
-
Vaccine Market in China
根据StrategyHelix, the vaccine market in China is expected to increase by US$ 2,663 期间百万 2021-2027, 复合年增长率为 7.7% 在预测期内.
-
PD-1 (PD-L1) Therapy Market in China
The PD-1 (PD-L1) therapy market in China is poised to grow by US$ 4,330 期间百万 2021-2027, 复合年增长率为 12.3% 在预测期内, 据数据和分析公司 StrategyHelix 称.
-
Melanoma Market in China
根据StrategyHelix的统计, the melanoma market in China, 就体积而言, 预计复合年增长率为 2.2% 未来五年.
-
Oncolytic Virus Therapy Market in China
The oncolytic virus therapy market in China is poised to grow by US$ 1,913 期间百万 2021-2027, 复合年增长率为 41.8% 在预测期内, 据数据和分析公司 StrategyHelix 称.